Catalog Products » TNFRSF19, His, Human
Manual
Manual
COAs

TNFRSF19, His, Human

A novel susceptibility gene TNFRSF19, which encodes an orphan member of the TNF receptor superfamily known to be associated with nasopharyngeal carcinoma (NPC) and lung cancer risk. TNFRSF19, a susceptibility gene for nasopharyngeal carcinoma and other cancers, functions as a potent inhibitor of the TGFβ signaling pathway.
$300.00
Z05900-100

Ask us a question
Product Introduction
Species Human
Protein Construction
TNFRSF19 (Glu30-Leu170)_x000D_
Accession # Q9NS68-1		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 16.55 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 25-40 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
Back

TNFRSF19, His, Human

The purity of TNFRSF19, His, Human is greater than 95% as determined by SEC-HPLC. »

TNFRSF19, His, Human

TNFRSF19, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »

<
>

Background
Target Background A novel susceptibility gene TNFRSF19, which encodes an orphan member of the TNF receptor superfamily known to be associated with nasopharyngeal carcinoma (NPC) and lung cancer risk. TNFRSF19, a susceptibility gene for nasopharyngeal carcinoma and other cancers, functions as a potent inhibitor of the TGFβ signaling pathway.
Synonyms TRADE; Toxicity and JNK inducer; Taj; Troy; AL023044; AW123854; TAJ-alpha; TAJ alpha
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.